Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Filings indexed 1,760 across all filing types
Latest filing 2024-08-14 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Clarification / Information on news item
Regulatory Filings Classification · 95% confidence The document is a letter from Torrent Pharmaceuticals Limited addressed to stock exchanges (BSE and NSE) providing clarification regarding a news item about a potential fundraising event. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosure of material events. The letter states that there is currently no material event requiring disclosure and that the company has complied with all disclosure obligations. The document is short (2380 characters) and serves as a regulatory clarification or response to an inquiry rather than a financial report or announcement of a specific event. It does not contain financial data, earnings, management changes, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance communications that do not fit other categories.
2024-08-14 English
Change in Management
Board/Management Information Classification · 100% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) informing about a change in senior management personnel. It specifically mentions the elevation of an individual to Executive Director from Vice President, with details provided in an annexure. The document references compliance with SEBI circulars related to disclosure of senior management changes. There is no financial data, no report attached or referenced as published, and the content focuses solely on management personnel changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS.
2024-08-13 English
Change in Senior Management Personnel
Board/Management Information Classification · 100% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) informing about a change in senior management personnel. It specifically mentions the elevation of an individual to Executive Director from Vice President, with details provided in an annexure. The document references compliance with SEBI circulars related to disclosure of senior management changes. There is no financial data, no report attached or referenced as published, and the content focuses solely on management personnel changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS.
2024-08-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document is a letter addressed to the stock exchange listing department, referencing a transcript of a conference call with analysts and investors regarding the financial results for the quarter ended June 30, 2024. It states that the transcript has been placed on the company's website and is not the transcript itself. The document length is only 1465 characters, indicating it is a brief announcement rather than the full transcript. According to the MENU VS MEAL RULE, this is an announcement about the availability of the transcript, not the transcript itself. Therefore, the appropriate classification is Call Transcript (CT) because the subject is a conference call transcript, but since the document only announces the transcript's availability and does not contain the transcript text, it fits best as a Regulatory Filing (RNS) as a fallback for such announcements. However, given the specific nature of the announcement about a call transcript, the best fit is Call Transcript (CT) with moderate confidence, acknowledging it is an announcement rather than the full transcript.
2024-07-29 English
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2024
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange listing department, referencing a transcript of a conference call with analysts and investors regarding the financial results for the quarter ended June 30, 2024. It states that the transcript has been placed on the company's website and is not the transcript itself. The document length is only 1465 characters, indicating it is a brief announcement rather than the full transcript. According to the rules, announcements about the availability of transcripts or reports, especially when short and providing a link, should be classified as Regulatory Filings (RNS) rather than the actual Call Transcript (CT).
2024-07-29 English
Shareholders meeting
Regulatory Filings
2024-07-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.